A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
Completed · Phase 3
Conditions studied: HIV Infections
In brief
To compare, in zidovudine (AZT)-naive patients, the safety, tolerance, and efficacy of saquinavir mesylate (Ro 31-8959) alone versus AZT alone versus AZT in combination with Ro 31-8959, zalcitabine (ddC), or both. To compare various disease markers among the different regimens.
Key facts
- Study ID
- NCT00002334
- Run by
- Hoffmann-La Roche
- People needed
- 3000
- Last updated by the study team
- 2005-06-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Concurrent Medication:
- Allowed:
- Erythropoietin and G-CSF.
- Concurrent Treatment:
- Allowed:
- Local skin radiotherapy.
- Patients must have:
- HIV infection.
- CD4 count 50 - 350 cells/mm3.
- No prior antiretroviral therapy OR less than 16 weeks of prior AZT.
- No acute serious opportunistic infections requiring immediate treatment.
- No unexplained fever persisting for 14 days within 90 days prior to study entry.
- No significant unexplained diarrhea persisting for 14 days within 30 days prior to study entry.
- No visceral Kaposi's sarcoma or lymphoma currently requiring chemotherapy and/or radiotherapy.
- Life expectancy of at least 80 weeks.
You may not qualify if…
- Co-existing Condition:
- Patients with the following symptoms or conditions are excluded:
- Malabsorption.
- Severe chronic diarrhea.
- Inadequate oral intake (unable to eat one or more meals daily because of chronic nausea, emesis, or abdominal/oral-esophageal discomfort).
- Any grade 3 or worse toxicity.
- Inability to comply with study requirements.
- Concurrent Medication:
- Excluded:
- Other investigational agents.
- Antineoplastic agents.
- Biologic response modifiers (including interferons).
- Foscarnet.
- Anti-HIV drugs other than the study drugs.
- Concurrent Treatment:
- Excluded:
- Radiotherapy (other than local skin radiotherapy).
- Patients with the following prior condition are excluded:
- History of non-Hodgkin's lymphoma.
- Prior Medication:
- Excluded:
- Acute therapy for opportunistic infection within 14 days prior to study entry.
- Prior HIV proteinase inhibitor.
Where it is running
- Phoenix Body Positive — Phoenix, Arizona, United States
- UCD Med Ctr — Sacramento, California, United States
- Davies Med Ctr — San Francisco, California, United States
- Mount Zion Med Ctr / UCSF — San Francisco, California, United States
- Pacific Oaks Med Group — Sherman Oaks, California, United States
- Sunnyvale Med Clinic — Sunnyvale, California, United States
- Novum Inc — Washington D.C., District of Columbia, United States
- Howard Univ — Washington D.C., District of Columbia, United States
- Miami Veterans Administration Med Ctr — Miami, Florida, United States
- Univ of Miami School of Medicine — Miami, Florida, United States
- Cook County Hosp — Chicago, Illinois, United States
- Rush Presbyterian - Saint Luke's Med Ctr — Chicago, Illinois, United States
- Tulane Univ Med School — New Orleans, Louisiana, United States
- Massachusetts Gen Hosp — Boston, Massachusetts, United States
- HIV Wellness Ctr / Univ Med Ctr — Las Vegas, Nevada, United States
- Beth Israel Med Ctr — New York, New York, United States
- Harkness Pavilion — New York, New York, United States
- Univ Hosp of Cleveland / Case Western Reserve Univ — Cleveland, Ohio, United States
- Univ of Oklahoma Health Science / Pharmacy Practice — Oklahoma City, Oklahoma, United States
- Novum Inc — Pittsburgh, Pennsylvania, United States
- Respiratory Associates — Corpus Christi, Texas, United States
- N Texas Ctr for AIDS & Clin Rsch — Dallas, Texas, United States
- Univ TX Galveston Med Branch — Galveston, Texas, United States
- Thomas Street Clinic / Baylor College of Medicine — Houston, Texas, United States
- Univ of Washington — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.